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Migraines in Mice? Minireview
Ellen J. Hess an allele of tottering that causes profound chronic ataxia
associated with pervasive Purkinje and granule cell lossDepartment of Neuroscience and Anatomy
throughout the anterior cerebellum and reduced cere-Pennsylvania State University College of Medicine
bellar size. Like tottering mice, spike and wave dis-Hershey, Pennsylvania 17033
charges have been detected in leaner mice, but the
paroxysmal convulsions are never observed. BecauseRecently, the ion channel mutations causing both famil-
of thedramatically different phenotypes, tg and tg1a wereial hemiplegic migraine (FHM)and episodic ataxia type-2
initially characterized as mutations of different genes(EA-2) were identified as defects in the human voltage-
(Sidman et al., 1965). However, like FHM and EA-2, ge-dependent calcium channel a1A subunit (Ophoff et al.,
netic linkage and complementation studies demon-1996). Simultaneous with the identification of the FHM/
strated that tg and tg1a are different alleles of a singleEA-2 gene defects, the mutations underlying the tot-
genetic locus.tering and leaner mouse phenotypes were identified as
Calcium Channel a1A Subunitsdefects in the murine voltage-dependent calcium chan-
Defects in the voltage-dependent calcium channel a1Anel a1A subunit (Fletcher et al., 1996). Because these
subunit have been identified in FHM and EA-2 in humansgenes are homologs, the mouse mutants tottering and
and in tottering and leaner mice. Voltage-dependentleaner may be instrumental in unraveling the pathogene-
calcium channels regulate several biologic functions in-sis of FHM and EA-2.
cluding neurotransmitter release and excitability by con-Inherited ion channel mutations or “channelopathies”
trolling the flux of calcium. These channels are charac-are the cause of several neurologic disorders in humans.
terized by voltage-sensitive activation in response toHypokalemic periodic paralysis, which is characterized
depolarization resulting in the selective increase in cal-by intermittent weakness, results from a calcium chan-
cium flux into the cell. The channel is then inactivatednel mutation (Ptacek et al., 1994), whereas hyperkalemic
and returned to its resting state. The kinetics and voltageperiodic paralysis is caused by a sodium channel muta-
dependence of activation and inactivation define the
tion (Cummins et al., 1993). Episodic ataxia type 1 is
specific calcium channel subtype as L, N, P/Q, or R (for
produced by a point mutation in a potassium channel
reviews see Catterall, 1995; Perez-Reyes and Schneider,(Browne et al., 1994). The distinguishing phenotypic fea-
1995; Wheeler et al., 1995). Calcium channels are com-
ture of these channelopathies is the transient nature of
posed of five subunits (a1, a2, b, g, and d); however,the neurologic dysfunctions which are characterized by
the a1 subunit alone is sufficient to form the structuralparoxysmal episodes of abnormal motor control and/or
channel and confer voltage sensitivity. The calcium
muscle tone. channel a1 subunit topology is very similar to the a1Both FHM and EA-2 patients also exhibit paroxysmal subunit of voltage-dependent sodium channels and is
neurologic dysfunction typical of the channelopathies characterized by four repeated units or domains (I–IV) of
(Griggs and Nutt, 1995). FHM is characterized by brief six alpha helical membrane spanning segments (S1–S6;
periods of hemiparesis or weakness accompanied by Figure 1). These four domains interact to form the
migraine headaches; although the patients generally re- pore, confer ion selectivity, and regulate voltage-sensi-
cover function, the hemiparesis can occur for hours, far tivity, while the a2, b, g, and d subunits modify these
outlasting the migraine. Further, cerebellar atrophy has characteristics.
also been noted in FHM patients. In contrast, EA-2 is At least six genes (A, B, C, D, E, and S) comprise the
associated with attacks of ataxia that are precipitated a1 subunit family, each with unique kinetic and pharma-
by stress or exercise; these prolonged episodes can last cologic properties. The a1A subunit encodes P- and
more than a day. EA-2 patients are essentially normal Q-type calcium channels which wereoriginally identified
between attacks but some EA-2 patients may also ex- in cerebellar Purkinje cells (Llinas et al., 1989) and gran-
hibit cerebellar atrophy. Although in retrospect, these ule cells (Zhang et al., 1993), respectively. Both P- and
two disorders appear to belong to a phenotypic contin- Q-type channels are high-voltage activated calcium
uum, they are unique clinical entities which few sus- channels. However, these channels can be distin-
pected were the result of mutations within the same guished by their pharmacologic properties and inactiva-
gene until EA-2 was mapped to the same interval tion kinetics; P-type channels do not inactivate during
as FHM. a 1 second depolarizing pulse whereas Q-type channels
The tottering (tg) mutation results in spike and wave rapidly inactivate. Differences in P- and Q-type inactiva-
discharges, mild ataxia, and intermittent convulsions. tion kinetics may be determined by a1A subunit splice
These mutants are characterized by spontaneous be- variants (Snutch et al., 1991), suggesting that alterations
havioral arrest associated with synchronous, bilateral in heteronuclear RNA processing caused by a mutation,
cortical polyspike discharges that last from 0.3–10 sec- such as those observed in EA-2 and tg1a, could have
onds, similar to those that occur in human absence a profound effect on the tissue-specific expression of
epilepsy (Noebels and Sidman, 1979). Tottering mice calcium channel subtypes.
also exhibit convulsions characterized by 20–40 minutes Are the Human and Mouse Calcium
of coordinated spasms and jerks of the limbs, trunk, Channel a1A Subunits Orthologs?
and face; similar to EA-2, these paroxysmal episodes The mouse and human calcium channel a1A subunits are
encoded by homologous genes. The predicted aminoare precipitated by stress. The leaner (tg1a) mutation is
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Figure 1. Membrane Topology of the Calcium Channel a1A Subunit with Approximate Positions of Human and Murine Mutations Identified to
Date
See text for details.
acid sequence of the mouse (GenBank U76716) and a1A Subunit Mutations
A total of eight different mutations have been identifiedhuman (GenBank M64373) calcium channels a1A subunit
are 94% identical with 97% amino acid similarity. Fur- in the a1A subunit (Figure 1). Four different mutations
that cause FHM have been identified in five unrelatedthermore, the transmembrane regions and the pore
forming domains, which confer functional specificity, families; all are missense point mutations. Two of these
mutations affect the S6 transmembrane alpha helices,exhibit even greater (99%) identity. Differences between
the sequences occur at the translational start site and regions that may form the intracellular mouth of the ion
pore (Catterall, 1995). Another FHM mutation missensein the intracellular loop between domains II and III. The
translational start site in mouse is apparently 46 amino mutation is located very close to the tottering point mu-
tation in the hairpin loop between S5 and S6. This is theacid residues downstream of the predicted start site for
both rat and human, which may be the result of alterna- pore-forming domain of the calcium channel, which is
thought to confer ion-selectivity to the channel (Yangtive splicing. Sequence differences in the long intracellu-
lar loop spanning domains II and III may also result et al, 1993). Thus, more than half the mutations so far
identified affect the pore itself and may compromisefrom splice variation as alternative splicing has been
observed in this segment (Snutch et al., 1991). Despite ion selectivity or permeability. The fourth FHM mutation
occurs in the voltage sensor S4 segment of domain Ithese differences, the high degree of sequence identity
between human and murine suggests these channels suggesting that the channel response to depolarization
may be compromised. Unlike the FHM and totteringsubserve similar functions.
The chromosomal position of the a1A subunit gene mutations, the mutations underlying EA-2 and leaner
cause gross disruptions in the a1A subunit. Mutations inis also consistent between human and mouse. Both
tottering and leaner mutations have been mapped close splice sites near the 39 end of the gene have been identi-
fied in an EA-2 patient and in leaner mice. Additionally,to Lyl1 and Junb on mouse chromosome 8. This region
of mouse chromosome 8 is syntenic with human chro- a single nucleotide deletion in the S1 segment of domain
III encodes a premature stop in the a1A subunit in anothermosome 19p13 where both FHM and EA-2 have been
mapped. The conservation of these chromosomal seg- EA-2 patient. The EA-2 and leaner mutations likely pro-
duce peptides that are not functional. The mutationsments between mouse and human strongly suggests
these genes are evolutionarily related. Furthermore, the identified to date appear to sort by phenotypic expres-
sion with alterations of a single residue representingdistribution of the a1A subunit mRNA is similar across
species; rhesus monkey and mouse both express a1A FHM and tottering while more profound defects in the
peptide structure define EA-2 and leaner.subunit mRNA at highest levels in the cerebellum with
moderately high levels in the cortex and less transcript Ion Channels and Paroxysmal Events
Altered ion permeability would clearly affect intercellularin the thalamus (Ophoff et al., 1996; Fletcher et al., 1996).
Little or no a1A subunit mRNA is detected outside the signaling and may precipitate the paroxysmal episodes.
But how can a channelopathy generate a prolongedcentral nervous system. Limited analysis of the a1A sub-
unit distribution inhuman isconsistent with these results paroxysmal event? The episodic events observed in
FHM/EA-2 and tottering/leaner generally last for tens ofdemonstrating high levels of expression in the cerebel-
lum (Volsen et al., 1995) and no expression detectable minutes to tens of hours; the shortest events, the spike
and wave discharges observed in tottering and leanerin lymphocytes. The sequence similarity, conservation
of synteny, and tissue-specific mRNA distribution sug- mice, last for several seconds. By contrast, calcium
channel activation and inactivation occur on the ordergest that the human and murine a1A subunit genes impli-
cated in FHM/EA-2 and tg/tg1a are orthologs. of milliseconds to at most seconds in vivo. It is difficult
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Zhang, J.F., Randall, A.D., Ellinor, P.T., Horne, W.A., Sather, W.A.,to directly reconcile the prolonged phenotypic events
Tanabe, T., Schwarz, T.L., and Tsien, R.W. (1993). Neuropharmacol-with the molecular events as even mutant channels are
ogy 32, 1075–1088.unlikely to sustain abnormal activity for such extended
periods. Both exocytotic release and neuronal electrical
properties are regulated by calcium channels. There-
fore, given the extended expression of the episodic phe-
notypes, these prolonged neurologic events are likely
to involve abnormal polysynaptic signaling generated
or sustained by the disrupted neurotransmission.
These mouse mutants may serve as direct animal
models of FHM and/or EA-2. The close proximity of the
tottering mutation toone of the FHM mutations suggests
the functional calcium channel defect may correspond
in both human and mouse. Furthermore, while the phe-
notypes expressed in man and mice are not identical,
they are very similar, mimicking both the paroxysmal
nature of the disorder and the cerebellar atrophy. Of
course, it is not reasonable to expect direct phenotypic
correspondence between mouse and human even
where the genetic defects are identical; this is especially
true for FHM since it is not clear that mice (tottering or
otherwise) experience migraine headaches. Nonethe-
less, these mice may provide a model for understanding
the relationship between migraine headaches and ion
channel misregulation. The genotypic and phenotypic
similarities between the channelopathies in humans and
the tottering mouse mutants suggest that tottering mice
will be extremely useful for determining how a channel-
opathy can generate prolonged paroxysmal neurologic
dysfunction in humans.
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